Survivorship Guidance for Patients with Colorectal Cancer
Effective therapy for treatment of colorectal cancer includes comprehensive and evidence-based therapies that may include a combination of surgery, chemotherapy, targeted therapy, and/or radiation. However, in order to provide patients with the highest quality of care, providers must consider all aspects of survivorship care including: surveillance for recurrence/second primaries, genetic counseling, psychosocial/physical late effects of cancer and its therapies, and preventative lifestyle strategies. Health systems, providers, and researchers need to identify systematic methods of addressing the unique needs of the survivorship population that include multidisciplinary teams including supportive oncology (i.e., psychologists, social workers), specialties (i.e., cardiology), and primary care physicians.
KeywordsColorectal neoplasms Survivorship Neoplasms Cancer Diet Exercise Recurrence Genetics
Compliance with Ethical Standards
Conflict of Interest
The authors declare they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Noone AM, Howlader N, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975–2015. https://seer.cancer.gov/csr/1975_2015/. Published 2018. Accessed November 18, 2018.
- 4.Bailey CE, Hu C-Y, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, et al. Increasing disparities in the age-related incidences of Colon and Rectal cancers in the United States, 1975-2010. JAMA Surg. 2015;150(1):17–22. https://doi.org/10.1001/jamasurg.2014.1756.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.• National Comprehensive Cancer Network. Colon Cancer (version 4.2018). https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accessed November 11, 2018. This is the most recent version of the NCCN guidelines for colon cancer that guides diagnosis and management of cancer.
- 6.• National Comprehensive Cancer Network. Rectal Cancer (Version 3.2018). https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf. Accessed November 11, 2018. This is the most recent version of the NCCN guidelines for rectal cancer that guides diagnosis, and management of cancer.
- 7.• El-Shami K, Oeffinger KC, Erb NL, et al. American Cancer Society colorectal cancer survivorship care guidelines. CA Cancer J Clin. 2015;65(6):427–55. https://doi.org/10.3322/caac.21286 These are the comprehensive recommendations from the American Cancer Society specifically addressing clinical survivorship needs for colorectal cancer.CrossRefGoogle Scholar
- 8.Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31(35):4465–70. https://doi.org/10.1200/JCO.2013.50.7442.CrossRefPubMedGoogle Scholar
- 9.Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2018;68(4):297–316. https://doi.org/10.3322/caac.21446.CrossRefPubMedGoogle Scholar
- 11.Kendal WS, Nicholas G. A population-based analysis of second primary cancers after irradiation for rectal cancer. Am J Clin Oncol. 2007;30(4):333–9. https://doi.org/10.1097/01.coc.0000258084.55036.9e.CrossRefPubMedGoogle Scholar
- 12.Wiltink LM, Nout RA, Fiocco M, Meershoek-Klein Kranenbarg E, Jürgenliemk-Schulz IM, Jobsen JJ, et al. No increased risk of second cancer after radiotherapy in patients treated for rectal or endometrial cancer in the randomized TME, PORTEC-1, and PORTEC-2 trials. J Clin Oncol. 2015;33(15):1640–6. https://doi.org/10.1200/JCO.2014.58.6693.CrossRefPubMedGoogle Scholar
- 14.• Stoffel EM, Mangu PB, Gruber SB, et al. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology clinical practice guideline endorsement of the familial risk-colorectal Cancer: European Society for Medical Oncology clinical practice guidelines. J Clin Oncol. 2015;33(2):209–17. https://doi.org/10.1200/JCO.2014.58.1322 This is a guidance document for clinicians to diagnosis and follow patients with hereditary syndromes.
- 15.Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL. Guideline development group, American College of Medical Genetics and Genomics Professional Practice and guidelines committee and National Society of genetic counselors practice guidelines committee. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of genetic counselors: referral indications for cancer predisposition assessment. Genet Med. 2015;17(1):70–87. https://doi.org/10.1038/gim.2014.147.CrossRefPubMedGoogle Scholar
- 16.• National Comprehensive Cancer Network. Genetic/familial high risk assessment: colorectal (version 1.2018). https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf. Accessed November 11, 2018. This is guidance information from NCCN of genetic/familial syndromes associated with colorectal cancer.
- 17.Hart TL, Charles ST, Gunaratne M, Baxter NN, Cotterchio M, Cohen Z, et al. Symptom severity and quality of life among long-term colorectal cancer survivors compared with matched control subjects: a population-based study. Dis Colon Rectum. 2018;61(3):355–63. https://doi.org/10.1097/DCR.0000000000000972.CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Sun V, Grant M, Wendel CS, McMullen CK, Bulkley JE, Altschuler A, et al. Dietary and behavioral adjustments to manage bowel dysfunction after surgery in long-term colorectal cancer survivors. Ann Surg Oncol. 2015;22(13):4317–24. https://doi.org/10.1245/s10434-015-4731-9.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Reese JB, Finan PH, Haythornthwaite JA, Kadan M, Regan KR, Herman JM, et al. Gastrointestinal ostomies and sexual outcomes: a comparison of colorectal cancer patients by ostomy status. Support Care Cancer. 2013;22(2):461–8. https://doi.org/10.1007/s00520-013-1998-x.CrossRefPubMedPubMedCentralGoogle Scholar
- 27.Schüring AN, Fehm T, Behringer K, Goeckenjan M, Wimberger P, Henes M, et al. Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: indications for fertility preservation. Arch Gynecol Obstet. 2017;297(1):241–55. https://doi.org/10.1007/s00404-017-4594-3.CrossRefPubMedPubMedCentralGoogle Scholar
- 32.•• National Comprehensive Cancer Network. Cancer-related fatigue (version 2.2018). https://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf. Accessed November 11, 2018. This is guidance information from NCCN on cancer related fatigue.
- 35.Herman MP, Kopetz S, Bhosale PR, Eng C, Skibber JM, Rodriguez-Bigas MA, et al. Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course. Int J Radiat Oncol Biol Phys. 2009;74(3):818–23. https://doi.org/10.1016/j.ijrobp.2008.08.054.CrossRefPubMedPubMedCentralGoogle Scholar
- 36.Holm T, Singnomklao T, Rutqvist L-E, Cedermark B. Adjuvant preoperative radiotherapy in patients with rectal carcinoma: adverse effects during long term follow-up of two randomized trials. Cancer. 1996;78(5):968–76. https://doi.org/10.1002/(SICI)1097-0142(19960901)78:5<968::AID-CNCR5>3.0.CO;2-8.CrossRefPubMedGoogle Scholar
- 37.van den Blink QU, Garcez K, Henson CC, Davidson SE, Higham CE. Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adults. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group, ed. Cochrane Database Syst Rev. 2018;114(21 (Suppl 1)):344. https://doi.org/10.1002/14651858.CD010604.pub2.CrossRefGoogle Scholar
- 41.USA Today/Kaiser Family Foundation/Harvard School of Public Health National Survey of Households Affected by Cancer. http://www.kff.org/kaiserpolls/pomr112006pkg.cfm. Accessed November 11, 2018.
- 43.Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist. 2013;18(4):381–90. https://doi.org/10.1634/theoncologist.2012-0279.CrossRefPubMedPubMedCentralGoogle Scholar
- 48.Jagsi R, Pottow JAE, Griffith KA, Bradley C, Hamilton AS, Graff J, et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol. 2014;32(12):1269–76. https://doi.org/10.1200/JCO.2013.53.0956.CrossRefPubMedPubMedCentralGoogle Scholar
- 53.Tevaarwerk AJ, Lee JW, Sesto ME, Buhr KA, Cleeland CS, Manola J, et al. Employment outcomes among survivors of common cancers: the symptom outcomes and practice patterns (SOAPP) study. J Cancer Surviv. 2013;7(2):191–202. https://doi.org/10.1007/s11764-012-0258-2.CrossRefPubMedPubMedCentralGoogle Scholar
- 54.Tevaarwerk AJ, Lee J-W, Terhaar A, Sesto ME, Smith ML, Cleeland CS, et al. Working after a metastatic cancer diagnosis: factors affecting employment in the metastatic setting from ECOG-ACRIN’s symptom outcomes and practice patterns study. Cancer. 2016;122(3):438–46. https://doi.org/10.1002/cncr.29656.CrossRefPubMedGoogle Scholar
- 59.Meyerhardt JA, Sato K, Niedzwiecki D, Ye C, Saltz LB, Mayer RJ, et al. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst. 2012;104(22):1702–11. https://doi.org/10.1093/jnci/djs399.CrossRefPubMedPubMedCentralGoogle Scholar
- 64.Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Nelson H, et al. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from cancer and leukemia group B 89803. J Clin Oncol. 2008;26(25):4109–15. https://doi.org/10.1200/JCO.2007.15.6687.CrossRefPubMedPubMedCentralGoogle Scholar
- 65.Gibson TM, Park Y, Robien K, Shiels MS, Black A, Sampson JN, et al. Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies. J Clin Oncol. 2014;32(35):4004–11. https://doi.org/10.1200/JCO.2014.56.8444.CrossRefPubMedPubMedCentralGoogle Scholar
- 67.Morey MC, Snyder DC, Sloane R, Cohen HJ, Peterson B, Hartman TJ, et al. Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. JAMA. 2009;301(18):1883–91. https://doi.org/10.1001/jama.2009.643.CrossRefPubMedPubMedCentralGoogle Scholar
- 69.Arem H, Pfeiffer RM, Engels EA, Alfano CM, Hollenbeck A, Park Y, et al. Pre- and postdiagnosis physical activity, television viewing, and mortality among patients with colorectal cancer in the National Institutes of Health-AARP diet and health study. J Clin Oncol. 2015;33(2):180–8. https://doi.org/10.1200/JCO.2014.58.1355.CrossRefPubMedGoogle Scholar
- 70.Courneya KS, Vardy JL, O'Callaghan CJ, Friedenreich CM, Campbell KL, Prapavessis H, et al. Effects of a structured exercise program on physical activity and fitness in Colon Cancer survivors: one year feasibility results from the CHALLENGE trial. Cancer Epidemiol Biomark Prev. 2016;25(6):969–77. https://doi.org/10.1158/1055-9965.EPI-15-1267.CrossRefGoogle Scholar
- 71.•• Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348(10):891–9. https://doi.org/10.1056/NEJMoa021735 This is a randomized double-blinded trial of aspirin as a chemopreventive agent against colorectal cancer. The findings of this study showed that low-dose aspirin has a moderate chemopreventive effect on adenomas in the large bowel.CrossRefPubMedGoogle Scholar
- 75.McCowan C, Munro AJ, Donnan PT, Steele RJC. Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality. Eur J Cancer. 2013;49(5):1049–57. https://doi.org/10.1016/j.ejca.2012.10.024.CrossRefPubMedGoogle Scholar
- 85.•• Institute of Medicine (2005) From Cancer Patient to Cancer Survivor: Lost in Translation. This landmark Institute of Medicine report raised awareness of the medical, functional, and psychosocial consequences of cancer and its treatment.Google Scholar
- 89.•• Oeffinger KC, McCabe MS. Models for delivering survivorship care. J Clin Oncol. 2006;24(32):5117–24. https://doi.org/10.1200/JCO.2006.07.0474 The aim of this publication is to provide a rationale for survivor health care and to articulate a taxonomy of models of survivor care that is applicable to both community practices and academic institutions.CrossRefPubMedGoogle Scholar